Duchenne muscular dystrophy (DMD) is a genetic disease that causes muscle weakness and motor skill difficulties due to the loss of muscle tissue from changes to dystrophin proteins. It mostly affects ...

Thirteen years of work by two leaders in Binghamton University's School of Pharmacy produced a drug designed to ease the symptoms of Duchenne muscular dystrophy while being free of commonly seen side ...

Pathologic changes of the X-chromosome gene for dystrophin give rise to Duchenne muscular dystrophy (DMD), and dystrophin -- which minimizes muscle fiber loss due to sarcolemma contraction damage when ...

Duchenne muscular dystrophy (DMD) is a genetic condition caused by a change, or mutation, in the DMD gene. This gene normally tells the body how to make dystrophin, a protein that helps protect ...

A new study led by researchers at Hospital for Special Surgery (HSS) suggests that currently available therapies may help control chronic muscle inflammation in Duchenne muscular dystrophy (DMD), a ...

Jon Anning, a Slippery Rock University professor, has done extensive research on effects and treatment for Duchenne muscular ...

Investigators based in Italy recently assessed the impacts of swallowing difficulties in a cohort of patients with DMD who presented to a single hospital with respiratory issues. The Swallowing ...

Caregivers of patients with Duchenne muscular dystrophy (DMD) experience notable work productivity loss, with high absenteeism and presenteeism rates, impacting their personal lives. Adult caregivers ...

The FDA approved Duvyzat (givinostat), a novel histone deacetylase (HDAC), for the treatment of patients six years of age and older with Duchenne muscular dystrophy (DMD). This approval marks an ...